CLX Medical, Inc. announced the resignation of the President/CEO and two members of the Board of Directors in anticipation of the company pursuing an acquisition to become the focus of its future operations. The Board accepted the resignation of President/CEO Steven R. Peacock effective July 20, 2009. On July 22, 2009, the Board appointed Director Bob McCoy to fill the positions of Interim Chief Executive Officer and Interim President. Also on July 22, 2009, Directors Jim Bickel and Pat Edgerton resigned as members of the Board. Bob McCoy is now the sole officer and director of the company. The management changes were undertaken in order to prepare the company for the process of an acquisition transaction. As part of that process, new management will be appointed to fill the vacated officer and director positions.

CLX Medical Inc. announced that the resignation of CEO Vera Leonard, effective March 16, 2009. After having achieved my goal of successfully identifying and acquiring a FDA cleared, CLIA waived product that offers CLX the opportunity to become market leader in an important healthcare sector.

CLX Medical, Inc.’s common stock has been deleted from OTC Bulletin Board effective February 18, 2009 on account of its failure to comply with NASD 6530. The company has been added to NBB.